Discordance between level of risk and intensity of evidence-based treatment in patients with acute coronary syndromes

V Michael Jelinek
Med J Aust 2007; 187 (8): . || doi: 10.5694/j.1326-5377.2007.tb01377.x
Published online: 15 October 2007

To the Editor: Scott and colleagues have shown that Australia is no different to the rest of the world in applying evidence-based treatment predominantly to patients at lower risk.1 They suggest that therapy may be withheld from high-risk patients because of over-estimation of the risk of treatment, under-estimation of the actual absolute risk of non-treatment, and consideration of cost-effectiveness and social inequalities.

  • V Michael Jelinek

  • St Vincent’s Hospital, Melbourne, VIC.



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.